Jean-Frederic Colombel(@JeanFredericCo1) 's Twitter Profileg
Jean-Frederic Colombel

@JeanFredericCo1

Director Inflammatory Bowel Disease Center Icahn School of Medicine at Mount Sinai New York

ID:1169966591506878465

calendar_today06-09-2019 13:32:49

963 تغريدات

4,8K متابعون

70 التالية

OCCAM Immune(@Occamimmune) 's Twitter Profile Photo

Founded by world-leading immunologists Miriam Merad, MD, PhD, Sacha Gnjatic, Seunghee Kim-Schulze, & Erik Wambre, OCCAM Immune offers biobanking and cutting-edge tools tailored for discovering immune biomarkers for patient stratification and the etiology of immune-mediated diseases.

Founded by world-leading immunologists @MiriamMerad, Sacha Gnjatic, Seunghee Kim-Schulze, & @WambreErik, OCCAM Immune offers biobanking and cutting-edge tools tailored for discovering immune biomarkers for patient stratification and the etiology of immune-mediated diseases.
account_circle
Shomron Ben-Horin(@ShomronH) 's Twitter Profile Photo

Study in Nature Communications by HabermanLab on the Urban-Rural diet-omic roots of IBD in China/Israel (our SOURCE Helmsley Charitable Trust consortium). Shows a gradient of IBD-like microbiome change correlating with time in city spent by villagers.
doi.org/10.1038/s41467…
Sheba Medical Center

account_circle
PREDICT IBD(@PREDICTIBD) 's Twitter Profile Photo

PHD STUDENT VISITING NYC 🗽

Linea Bonfils is currently a visiting researcher at Icahn School of Medicine at Mount Sinai. She works with data from the unique MECONIUM cohort.

A big thank you to Manasi Agrawal, MD, MS, Jean-Frederic Colombel, , and all of Peter lab for welcoming this collaboration.

PHD STUDENT VISITING NYC 🗽 @BonfilsLinea is currently a visiting researcher at @IcahnMountSinai. She works with data from the unique MECONIUM cohort. A big thank you to @ManasiAgrawalMD, @JeanFredericCo1, #IngaPeter, and all of Peter lab for welcoming this collaboration.
account_circle
ignacio catalan(@ign76) 's Twitter Profile Photo

Interested in how to predict (and eventually prevent) IBD?

We are not alone!

🧠 Here on Multiple Sclerosis prediction years before diagnosis

👇🏻👇🏻👇🏻

account_circle
GlycanTrigger(@GlycanTrigger) 's Twitter Profile Photo

🌟Wrapping up day 1 of our 2nd GlycanTrigger General Assembly Meeting in Leiden!💭It is been a productive day with many fruitful discussions🙌WP1, 3, 4 and 6 had the opportunity to report 2023 activities and the action plan for 2024, and discuss their latest research findings🔍

🌟Wrapping up day 1 of our 2nd GlycanTrigger General Assembly Meeting in Leiden!💭It is been a productive day with many fruitful discussions🙌WP1, 3, 4 and 6 had the opportunity to report 2023 activities and the action plan for 2024, and discuss their latest research findings🔍
account_circle
GlycanTrigger(@GlycanTrigger) 's Twitter Profile Photo

📅 This week, GlycanTrigger team is meeting in Leiden for our 2nd General Assembly Meeting
🔬The project is on a mission to find a way to intercept chronic inflammation by studying how changes in glycans impact the initiation of the inflammatory process
🚀Stay tuned!

📅 This week, @GlycanTrigger team is meeting in Leiden for our 2nd General Assembly Meeting 🔬The project is on a mission to find a way to intercept chronic inflammation by studying how changes in glycans impact the initiation of the inflammatory process 🚀Stay tuned!
account_circle
Joseph Sleiman, MD(@JosephHabibi_MD) 's Twitter Profile Photo

When the pouch is sick, who do you call?

Pouchitis-buster Maia Kayal MD takes us on the journey of evidence (& lack thereof) in the realm of IPAAs

Full recordings w/registration EBMed.net

When the pouch is sick, who do you call? Pouchitis-buster @MaiaKayalMD takes us on the journey of evidence (& lack thereof) in the realm of IPAAs Full recordings w/registration #EBMED EBMed.net
account_circle
Robert Dudkowiak MD, PhD(@drRobinDud) 's Twitter Profile Photo

Amazing 🗞️ paper abt MoAction one of the most 🔐 precision biologic in treatment since 2015

🗝️ 🔓

👉 Anti-α4β7 therapy results in a decrease ⬇️ of B & T cells in🎯 intestinal mucosa of patients

Science Immunology

doi.org/10.1126/sciimm…

Amazing 🗞️ paper abt MoAction one of the most 🔐 precision biologic in #UlcerativeColitis treatment since 2015 🗝️ 🔓 #Vedolizumab 👉 Anti-α4β7 therapy results in a decrease ⬇️ of #naïve B & T cells in🎯 intestinal mucosa of #UC patients @SciImmunology doi.org/10.1126/sciimm…
account_circle
ignacio catalan(@ign76) 's Twitter Profile Photo

Fascinating study on Vedolizumab mechanism of action in Ulcerative colitis in Science Immunology by Mehandru Lab @MountSinai

Saved for reading after the weekend!⛵️

👇🏻👇🏻👇🏻

account_circle
Jean-Frederic Colombel(@JeanFredericCo1) 's Twitter Profile Photo

Unappreciated MOA of vedolizumab with major implications including new perspectives for precision medicine

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis. pubmed.ncbi.nlm.nih.gov/38640252/

account_circle
Manasi Agrawal, MD, MS(@ManasiAgrawalMD) 's Twitter Profile Photo

Robert Battat MD Gil Kaplan MD MPH Aline Charabaty, MD, FACG, AGAF Indeed. Our pilot analysis of serum samples from a military cohort also demonstrated a strong association bw PFAS and IBD. Much work to be done in this space. pubmed.ncbi.nlm.nih.gov/38154728/

account_circle